Weight-loss giant Novo Nordisk's shares rose over 5% on Friday to a high last touched in October, driven by "encouraging" early U.S. prescription data for its Wegovy pill, which the firm hopes will ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
New! Sign up for our free email newsletter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results